Almanack Investment Partners, Llc. Lixte Biotechnology Holdings, Inc. Transaction History

Almanack Investment Partners, Llc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.12 - $0.35 $59,520 - $173,600	-496,000 Reduced 66.66%	248,084 $185,000
Q1 2022 May 13, 2022	SELL	$0.16 - $0.35 $5,600 - $12,250	-35,000 Reduced 4.49%	744,084 $915,000
Q4 2021 Feb 11, 2022	SELL	$0.21 - $0.57 $5,662 - $15,370	-26,966 Reduced 3.35%	779,084 $927,000
Q3 2021 Nov 04, 2021	SELL	$0.52 - $0.85 $91,517 - $149,596	-175,996 Reduced 17.92%	806,050 $1.68 Million
Q2 2021 Aug 04, 2021	SELL	$0.46 - $0.89 $27,627 - $53,452	-60,059 Reduced 5.76%	982,046 $2.98 Million
Q1 2021 May 11, 2021	BUY	$0.8 - $1.2 $833,684 - $1.25 Million	1,042,105 New	1,042,105 $3.43 Million

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33.6M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.